Letrozole and Tamoxifen Interaction

Monitor
Researched 90% confidence

Letrozole and Tamoxifen have an interaction requiring monitoring for interaction with 90% confidence. Unlike anastrozole, letrozole does not appear to significantly reduce endoxifen concentrations. However, combining a SERM with an aromatase inhibitor can lead to excessive estrogen suppression. Use with caution and monitor estradiol levels and symptoms. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.

Compound Profiles

Letrozole

Aromatase Inhibitor | Potent Estrogen Suppression

Letrozole competitively and reversibly binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), inhibiting its catalytic activity with greater potency than any other commercially available aromatase inhibitor. Aromatase catalyzes the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~2 days (48 hours) Typical dose: 0.25-0.5mg EOD (on-cycle); 2.5mg/day (medical) pct, anabolic
aromatase androgenicaromatase inhibitorhepatotoxichpta suppressive
View full profile

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Half-life: ~5-7 days Typical dose: 20-40mg oral daily pct
cyp3a4estrogen receptor anticoagulantcarcinogenic riskhepatotoxicpct agent
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Letrozole, Tamoxifen). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the pct-agent safety flag (Letrozole, Tamoxifen). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Letrozole, Tamoxifen). Monitor accordingly.

Frequently Asked Questions

Can I take Letrozole with Tamoxifen?

Yes, but with caution. Unlike anastrozole, letrozole does not appear to significantly reduce endoxifen concentrations. However, combining a SERM with an aromatase inhibitor can lead to excessive estrogen suppression. Use with caution and monitor estradiol levels and symptoms. Regular monitoring is advised.

Is Letrozole and Tamoxifen safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: hepatotoxic, pct agent, teratogenic. Monitor accordingly.

What are the interactions between Letrozole and Tamoxifen?

Unlike anastrozole, letrozole does not appear to significantly reduce endoxifen concentrations. However, combining a SERM with an aromatase inhibitor can lead to excessive estrogen suppression. Use with caution and monitor estradiol levels and symptoms. This assessment has 90% confidence and is based on documented research data.

How should I time Letrozole and Tamoxifen?

Letrozole has a half-life of ~2 days (48 hours) and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Letrozole vs Tamoxifen

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.